In Quest of Tomorrow's Medicines
(Sprache: Englisch)
An eminent scientist talks about the pharmaceutical industry, biotechnology and the future of drug research. In the course of our busy, technologically-driven lives, it is taken for granted that we respond to minor fluctuations in our health by taking...
Leider schon ausverkauft
versandkostenfrei
Bisher Fr. 59.90
Buch (Kartoniert) -20%
Fr. 47.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „In Quest of Tomorrow's Medicines “
Klappentext zu „In Quest of Tomorrow's Medicines “
An eminent scientist talks about the pharmaceutical industry, biotechnology and the future of drug research. In the course of our busy, technologically-driven lives, it is taken for granted that we respond to minor fluctuations in our health by taking pills - pills for headache and for toothache; sleeping pills and tranquilizers; pills to lower fever, quiet coughs, and clear the sinuses; medicines to reduce appetite; preparations to relieve heartburn; and many more. In the war against serious disease, medicines are an indispensable weapon in the physician's arsenal: they save lives, or at least prolong them and make them more bearable. Despite the important role that pharmaceuticals play in our lives, few of us know where medicines come from or how the pharmaceutical industry discovers and develops new drugs. Jürgen Drews, an acclaimed leader in the pharmaceutical industry, tells the fascinating story of drug discovery and development from his years of successfully leading international research teams at Hoffman-LaRoche. Drews traces the history of modern drug development from pharmacies, chemical companies, and individual entrepreneurs in Switzerland, Germany and the U.S. to the mega-corporations that dot the landscape of Europe, Japan and America. He describes the process by which new drugs are tested and brought to market, including a provocative look at how AIDS activism stimulated the approval process in the U.S. Drews' commentary on the role of clinical trials - the time involved and their cost - is sobering testimony to the complexity of bringing innovation to the marketplace. In the final two chapters of "In Quest of Tomorrow's Medicines", Drews offers an important and critical analysis of research in the pharmaceutical industry, pointing to strategies that work and management practices that impede progress.
An eminent scientist talks about the pharmaceutical industry, biotechnology and the future of drug research. In the course of our busy, technologically-driven lives, it is taken for granted that we respond to minor fluctuations in our health by taking pills - pills for headache and for toothache; sleeping pills and tranquilizers; pills to lower fever, quiet coughs, and clear the sinuses; medicines to reduce appetite; preparations to relieve heartburn; and many more. In the war against serious disease, medicines are an indispensable weapon in the physician's arsenal: they save lives, or at least prolong them and make them more bearable. Despite the important role that pharmaceuticals play in our lives, few of us know where medicines come from or how the pharmaceutical industry discovers and develops new drugs. Jürgen Drews, an acclaimed leader in the pharmaceutical industry, tells the fascinating story of drug discovery and development from his years of successfully leading international research teams at Hoffman-LaRoche. Drews traces the history of modern drug development from pharmacies, chemical companies, and individual entrepreneurs in Switzerland, Germany and the U.S. to the mega-corporations that dot the landscape of Europe, Japan and America. He describes the process by which new drugs are tested and brought to market, including a provocative look at how AIDS activism stimulated the approval process in the U.S. Drews' commentary on the role of clinical trials - the time involved and their cost - is sobering testimony to the complexity of bringing innovation to the marketplace. In the final two chapters of "In Quest of Tomorrow's Medicines", Drews offers an important and critical analysis of research in the pharmaceutical industry, pointing to strategies that work and management practices that impede progress.
Inhaltsverzeichnis zu „In Quest of Tomorrow's Medicines “
Drugs, Patients and the Pharmaceutical Industry: The Role of Drugs in the Practice of Medicine; The Role of the Pharmaceutical Industry in the Medical Use of Drugs.- THE HISTORY OF THE PHARMACEUTICAL INDUSTRY: The Development of the Pharmaceutical Industry; Natural Substances as Drugs.- DRUG RESEARCH MERGING EXPERIMENTAL PHARMACOLOGY AND CHEMISTRY: The Origins of Heterocyclic Chemistry; Dyes as Drugs: The Birth of Chemotherapy.- TECHNOLOGICAL ADVANCES AND A PARADIGM SHIFT IN DRUG RESEARCH: Technological Advance - Positive Crises; The Influence of Molecular Biology on Medicine.- A MEDICINE IS BORN - RESEARCH, DEVELOPMENT AND REGISTRATION: Research Strategies; What is Development? Requirements for Drug Approval and Safety; Development as Process.- MANAGEMENT OF INNOVATION: DIRECTING RESEARCH AND DEVELOPMENT: Two Cultures; Management of Research.- THE FUTURE OF RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY: Strategic Options; Focus of Innovation: The Biotechnology Industry; Centers of Innovation in the University; Future Pharmaceuticals Scenarios; Connections Between Basic Research and Pharmaceutical Innovation.Autoren-Porträt von Jürgen Drews
Jürgen Drews wurde 1933 in Berlin geboren. Er studierte Medizin, habilitierte sich und wurde Professor für Innere Medizin in Heidelberg und Molekulare Genetik in New Jersey, USA. Von 1976 bis 1988 leitete er die weltweite Forschung und Entwicklung grosser international tätiger Pharma-Firmen, zuletzt als Mitglied der Konzernleitung bei Hoffmann-La Roche.Er ist heute freiberuflich tätig und lebt in der Nähe von München und in Naples, USA. 2004 erhielt er den Beckmann Preis der American Laboratory Association für bedeutende Beiträge zur Arzneimittelforschung. Drews veröffentlichte zahlreiche wissenschaftliche Artikel und ist Herausgeber und Autor vieler Fachbücher, z.B. In Quest of Tomorrow's Medicines (Springer, New York 2000). Daneben publizierte er mehrere Romane, u.a. El Mundo oder die Leugnung der Vergänglichkeit (2003), Menschengedenken (2005), Das Mörderspiel (2006) sowie Erzählungen und Gedichtbände.
Bibliographische Angaben
- Autor: Jürgen Drews
- 2003, Softcover reprint of the original 1st ed. 1999, VI, 272 Seiten, Masse: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Übersetzer: D. Kramer
- Verlag: Springer, Berlin
- ISBN-10: 0387955429
- ISBN-13: 9780387955421
- Erscheinungsdatum: 14.01.2003
Sprache:
Englisch
Rezension zu „In Quest of Tomorrow's Medicines “
"A comprehensive story of drug research with all its glorious successes, its paradigm shifts, its new strategies, and its crisis at the brink of the 21st century, where new players have already moved into areas, which for a long time appeared to be reserved for the pharmaceutical industry. Told as a thrilling story." (Martin Hicklin, Basler Zeitung, Switzerland)
Pressezitat
"A comprehensive story of drug research with all its glorious successes, its paradigm shifts, its new strategies, and its crisis at the brink of the 21st century, where new players have already moved into areas, which for a long time appeared to be reserved for the pharmaceutical industry. Told as a thrilling story." (Martin Hicklin, Basler Zeitung, Switzerland)
Kommentar zu "In Quest of Tomorrow's Medicines"
0 Gebrauchte Artikel zu „In Quest of Tomorrow's Medicines“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "In Quest of Tomorrow's Medicines".
Kommentar verfassen